Role of 3β-Hydroxysteroid-Δ24 Reductase in Mediating Anti-Inflammatory Effects of High-Density Lipoproteins in Endothelial Cells McGrath KCY1*, Li XH1*, Puranik R1,2, Liong EC1, Tan JTM1, Dy VM1, Di Bartolo B1,2, Barter PJ1,2, Rye KA1,2,3, Heather AK1,2 1. Heart Research Institute, Camperdown, NSW, Australia 2. Discipline of Medicine, University of Sydney, Sydney, NSW, Australia 3. Department of Medicine, University of Melbourne, Melbourne, VIC, Australia Note: * Kristine McGrath and Xiao-Hong Li contributed equally to this manuscript Running Title: McGrath: Anti-inflammatory effects of HDLs Corresponding Author and Reprint Request Dr Alison Heather Heart Research Institute 114 Pyrmont Bridge Road Camperdown, NSW, 2050, Australia Ph: 612 8208 8900 Fax: 612 9565 5584 Email:
[email protected] Word Counts: Body including references, figure legends, tables: 4688 Abstract: 194 Total number of figures and tables: 5 ABSTRACT Objective: To investigate the ability of high density lipoproteins (HDLs) to up- regulate genes with the potential to protect against inflammation in endothelial cells. Methods and Results: Human coronary artery endothelial cells (HCAECs) were exposed to reconstituted HDLs (rHDLs) for 16 hours before being activated with tumor necrosis factor-α (TNF-α) for 5 hours. rHDLs decreased vascular cell adhesion molecule-1 (VCAM-1) promoter activity by 75% (P<0.05), via the nuclear factor- kappa B (NF-κB) binding site. rHDLs suppressed the canonical NF-κB pathway and decreased many NF-κB target genes. Suppression of NF-κB and VCAM-1 expression by rHDLs or native HDLs was dependent on an increase in 3β-hydroxysteroid-Δ24 reductase (DHCR24) levels (P<0.05).